Real-time enrollment status for this solid tumor, adult clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:30 AM UTC
| NCT Number | NCT04282044 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor, Adult |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 3 sites in the US |
| Sponsor | BioEclipse Therapeutics |
| Last Updated on CT.gov | February 8, 2024 (Feb 8, 2024) |
As of July 18, 2026: Clinical trial NCT04282044 is currently recruiting participants. This phase1 study for solid tumor, adult is actively seeking new participants at 3 locations across the United States. The study is sponsored by BioEclipse Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04282044 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04282044 was last updated Feb 8, 2024 (February 8, 2024). HelloStudys verifies this status automatically.